Search
Search
ASRS: 2025
Robert L. Avery, MD
Show Description +
Dr. Avery shares the 1-year results of the phase 2 pharmacodynamic study of ABBV-RGX-314, an investigational gene therapy for the treatment of wet AMD.
Posted: 8/06/2025
Robert L. Avery, MD
Dr. Avery shares the 1-year results of the phase 2 pharmacodynamic study of ABBV-RGX-314, an investigational gene therapy for the treatment of wet AMD.
Posted: 8/06/2025
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2025.
Please log in to leave a comment.